+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Using Galleria mellonella-Candida albicans infection model to evaluate antifungal agents



Using Galleria mellonella-Candida albicans infection model to evaluate antifungal agents



Biological and Pharmaceutical Bulletin 36(9): 1482-1487



Candida albicans is the most common fungal pathogen. Galleria mellonella is widely used as an infection model host. Nevertheless, the G. mellonella-C. albicans infection model had not been optimized for drug evaluation before this study. In this work, we revealed that 5 × 10(5) colony forming unit (CFU)/larva was a suitable inoculum to optimize the G. mellonella-C. albicans infection model in order to evaluate antifungal agents. Using our optimized model, the antifungal effect of fluconazole, amphotericin B and flucytosine, and the synergy between amphotericin B and flucytosine were successfully verified. Thus, this study provides a rapid, inexpensive and reliable way to evaluate antifungals in vivo.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 056810744

Download citation: RISBibTeXText

PMID: 23995660


Related references

Using Galleria mellonellaCandida albicans Infection Model to Evaluate Antifungal Agents. Biological & Pharmaceutical Bulletin 36(9): 1482-1487, 2013

Comprehensive approach for the detection of antifungal compounds using a susceptible strain of Candida albicans and confirmation of in vivo activity with the Galleria mellonella model. Phytochemistry 105: 68-78, 2014

Selective photoinactivation of Candida albicans in the non-vertebrate host infection model Galleria mellonella. Bmc Microbiology 13: 217, 2013

Acetylcholine Protects against Candida albicans Infection by Inhibiting Biofilm Formation and Promoting Hemocyte Function in a Galleria mellonella Infection Model. Eukaryotic Cell 14(8): 834-844, 2015

Virulence of Candida haemulonii complex in Galleria mellonella and efficacy of classical antifungal drugs: a comparative study with other clinically relevant non-albicans Candida species. Fems Yeast Research 18(7):, 2018

Adaptation of a Gaussia princeps Luciferase reporter system in Candida albicans for in vivo detection in the Galleria mellonella infection model. Virulence 6(7): 684-693, 2015

Proteomic Analysis of the Responses of Candida albicans during Infection of Galleria mellonella Larvae. Journal of Fungi 5(1):, 2019

Lactobacillus species increase the survival of Galleria mellonella infected with Candida albicans and non-albicans Candida clinical isolates. Medical Mycology 57(3): 391-394, 2019

Galleria mellonella larva model in evaluating the effects of biofilm in Candida albicans. Mikrobiyoloji Bulteni 51(1): 32-40, 2017

Effect of pre-incubation temperature on susceptibility of Galleria mellonella larvae to infection by Candida albicans. Mycopathologia 165(1): 5, 2008

In vivo activity of fluconazole/tetracycline combinations in Galleria mellonella with resistant Candida albicans infection. Journal of Global Antimicrobial Resistance 13: 74-80, 2018

Physical stress primes the immune response of Galleria mellonella larvae to infection by Candida albicans. Microbes and Infection 10(6): 628-634, 2008

Lactobacillus paracasei modulates the immune system of Galleria mellonella and protects against Candida albicans infection. Plos one 12(3): E0173332, 2017

Galleria mellonella as a host model to study Candida glabrata virulence and antifungal efficacy. Virulence 8(8): 1909-1917, 2017

Effect of different wavelengths and dyes on Candida albicans: In vivo study using Galleria mellonella as an experimental model. Photodiagnosis and Photodynamic Therapy 18: 34-38, 2017